The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with Leis...
Leishmaniasis, Visceral/etiology,
Drug Therapy, Combination,
HIV Infections/complications,
Anti-Retroviral Agents/therapeutic use,
Africa, Eastern,
Asia, Southeastern,
Anthelmintics/therapeutic use,
Leishmaniasis, Visceral/drug therapy,
Coinfection/complications
La presente guía establece los criterios técnicos para el diagnóstico y tratamiento de la hepatitis crónica secundaria a hepatitis viral B con la finalidad de contribuir a reducir la morbimortalidad de esta enfermedad. Da las definiciones para comprender las recomendaciones aquí dadas. Descripción ...
These guidelines aim to provide evidence-based recommendations on the care and treatment of persons diagnosed with chronic hepatitis C infection. They update the care and treatment section of the WHO Guidelines for the screening, care and treatment of persons with hepatitis C infection issued in April 20...
Hepatitis C, Chronic/complications,
Hepatitis C, Chronic/drug therapy,
HIV Infections/complications,
Hepatitis C, Chronic/diagnosis,
Coinfection,
Antiviral Agents/administration & dosage,
Drug Therapy, Combination
These consolidated guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the care of people living with HIV and the use of antiretroviral (ARV) drugs for treating and preventing HIV infection. They are structured along the continuum of HIV testing, care and treatme...
